
On Tuesday, Novo Nordisk completed the acquisition of Emisphere Technologies, according to a statement from the pharmaceutical giant.
"The adoption of the merger agreement was approved by Emisphere shareholders today," writes Novo Nordisk in the announcement. In November, the US authorities granted the firm an early termination of the waiting period.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app